BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7763284)

  • 21. P2-purinoceptors mediating spasm of the isolated uterus of the non-pregnant guinea-pig.
    Piper AS; Hollingsworth M
    Br J Pharmacol; 1996 Apr; 117(8):1721-9. PubMed ID: 8732282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence that [3H]-alpha,beta-methylene ATP may label an endothelial-derived cell line 5'-nucleotidase with high affinity.
    Michel AD; Chau NM; Fan TP; Frost EE; Humphrey PP
    Br J Pharmacol; 1995 Jul; 115(5):767-74. PubMed ID: 8548175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for P2-purinoceptor-mediated inhibition of noradrenaline release in rat brain cortex.
    von Kügelgen I; Späth L; Starke K
    Br J Pharmacol; 1994 Nov; 113(3):815-22. PubMed ID: 7858872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A P2 purinoceptor activated by ADP in rat medullar neurons.
    Ikeuchi Y; Nishizaki T; Okada Y
    Neurosci Lett; 1995 Sep; 198(2):71-4. PubMed ID: 8592644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PPADS: an antagonist at endothelial P2Y-purinoceptors but not P2U-purinoceptors.
    Brown C; Tanna B; Boarder MR
    Br J Pharmacol; 1995 Nov; 116(5):2413-6. PubMed ID: 8581277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoradiographic labelling of P2 purinoceptors in the guinea-pig cochlea.
    Mockett BG; Bo X; Housley GD; Thorne PR; Burnstock G
    Hear Res; 1995 Apr; 84(1-2):177-93. PubMed ID: 7642450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological characterization of ATP receptors in ampulla from frog semicircular canal.
    Butlen D; Bernard C; Ferrary E
    Am J Physiol; 1998 Jul; 275(1):R253-61. PubMed ID: 9688986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein kinase C isoforms in bovine aortic endothelial cells: role in regulation of P2Y- and P2U-purinoceptor-stimulated prostacyclin release.
    Patel V; Brown C; Boarder MR
    Br J Pharmacol; 1996 May; 118(1):123-30. PubMed ID: 8733584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of purinergic P2Y receptor subtypes by INS-1 insulinoma beta-cells: a molecular and binding characterization.
    Lugo-Garcia L; Filhol R; Lajoix AD; Gross R; Petit P; Vignon J
    Eur J Pharmacol; 2007 Jul; 568(1-3):54-60. PubMed ID: 17509560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for requirement of tyrosine phosphorylation in endothelial P2Y- and P2U- purinoceptor stimulation of prostacyclin release.
    Bowden A; Patel V; Brown C; Boarder MR
    Br J Pharmacol; 1995 Nov; 116(6):2563-8. PubMed ID: 8590971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of P2 purinergic receptors of aortic endothelial cells with those of adrenal medulla: evidence for heterogeneity of receptor subtype and of inositol phosphate response.
    Allsup DJ; Boarder MR
    Mol Pharmacol; 1990 Jul; 38(1):84-91. PubMed ID: 2164632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of divalent cations on the potency of ATP and related agonists in the rat isolated vagus nerve: implications for P2 purinoceptor classification.
    Trezise DJ; Bell NJ; Kennedy I; Humphrey PP
    Br J Pharmacol; 1994 Oct; 113(2):463-70. PubMed ID: 7834197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P2Y purinoceptors in gastric gland plasma membranes.
    Vallejo AI; Bo X; Burnstock G
    Eur J Pharmacol; 1996 Sep; 312(2):209-14. PubMed ID: 8894598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenosine-5'-O-(2-thiodiphosphate) is a potent agonist at P2 purinoceptors mediating insulin secretion from perfused rat pancreas.
    Bertrand G; Chapal J; Puech R; Loubatières-Mariani MM
    Br J Pharmacol; 1991 Mar; 102(3):627-30. PubMed ID: 1364829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ATP, a partial agonist of atypical P2Y purinoceptors in rat brain microvascular endothelial cells.
    Feolde E; Vigne P; Breittmayer JP; Frelin C
    Br J Pharmacol; 1995 Aug; 115(7):1199-203. PubMed ID: 7582545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK 293 cells; involvement of the P2Y13 receptor-type.
    Wirkner K; Schweigel J; Gerevich Z; Franke H; Allgaier C; Barsoumian EL; Draheim H; Illes P
    Br J Pharmacol; 2004 Jan; 141(1):141-51. PubMed ID: 14662731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ontogeny of P2-purinoceptors in the longitudinal muscle and muscularis mucosae of the rat isolated duodenum.
    Brownhill VR; Hourani SM; Kitchen I
    Br J Pharmacol; 1997 Sep; 122(2):225-32. PubMed ID: 9313929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discrimination by PPADS between endothelial P2Y- and P2U-purinoceptors in the rat isolated mesenteric arterial bed.
    Ralevic V; Burnstock G
    Br J Pharmacol; 1996 May; 118(2):428-34. PubMed ID: 8735648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of purinoceptors mediating depolarization of rat isolated vagus nerve.
    Trezise DJ; Kennedy I; Humphrey PP
    Br J Pharmacol; 1993 Nov; 110(3):1055-60. PubMed ID: 8298793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FPL 66096: a novel, highly potent and selective antagonist at human platelet P2T-purinoceptors.
    Humphries RG; Tomlinson W; Ingall AH; Cage PA; Leff P
    Br J Pharmacol; 1994 Nov; 113(3):1057-63. PubMed ID: 7858849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.